Notice Concerning Adoption As "Developing Biopharmaceutical Manufacturing Sites To Strengthen Vaccine Production Project" Offered By Meti

Meiji Holdings

03/10/2022 02:11

Oct 3 (Reuters) - Meiji Holdings Co Ltd  2269.T :
    * NOTICE CONCERNING ADOPTION AS "DEVELOPING
BIOPHARMACEUTICAL
MANUFACTURING SITES TO STRENGTHEN VACCINE PRODUCTION PROJECT"
OFFERED BY METI

Source text for Eikon:  ID:nTSvc83a40 
Further company coverage:  2269.T